News

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
New Trump vaccine policy might limit access to your future COVID shots: 10 points
The US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for ...
JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News
JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This ...
Explore more
RFK Jr. pledged not to upend US vaccine system, but big changes are underway
WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by ...